John L. Brottem - Apr 18, 2022 Form 4 Insider Report for Outset Medical, Inc. (OM)

Role
General Counsel
Signature
John L Brottem
Stock symbol
OM
Transactions as of
Apr 18, 2022
Transactions value $
-$81,552
Form type
4
Date filed
4/18/2022, 07:34 PM
Previous filing
Mar 17, 2022
Next filing
May 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OM Common Stock Options Exercise $9.48K +1K +2.94% $9.48 35K Apr 18, 2022 Direct
transaction OM Common Stock Sale -$43.2K -1K -2.86% $43.25 34K Apr 18, 2022 Direct F1, F2
transaction OM Common Stock Options Exercise $13.4K +1.42K +4.16% $9.48 35.4K Apr 18, 2022 Direct
transaction OM Common Stock Sale -$61.2K -1.42K -3.99% $43.25 34K Apr 18, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OM Non-Qualified Stock Option (right to buy) Options Exercise $0 -1.42K -3.57% $0.00 38.2K Apr 18, 2022 Common Stock 1.42K $9.48 Direct F3
transaction OM Performance Options (right to buy) Options Exercise $0 -1K -30.63% $0.00 2.27K Apr 18, 2022 Common Stock 1K $9.48 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 12, 2021.
F2 The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $42.00-$42.99 - 672 shares; $43.00-$43.99 - 1,743 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 This option vests 25% on May 26, 2021 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.
F4 In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested.